The board of directors at its meeting held today has recommended a dividend of Rs. 2.5/- (125%) per equity share of face value of Rs. 2/- for the financial year ended March 31, 2025

pdf

Jagsonpal Pharmaceuticals Ltd.

06 May 2025

220.72

1.76%

Result

Jagsonpal Pharmaceuticals Ltd - 507789 - Audited (Standalone) Financial Results For The Year Ended March 31, …

BSE India

Audited (Standalone) Financial Results for the year ended March 31, 2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	61.33	76.35	45.97	-19.7%	33.4%
Operating Profit Qtr	8.71	15.83	2.67	-45.0%	226.2%
Net Profit Qtr	6.58	31.99	3.55	-79.4%	85.4%
Earning Per Share Adjusted latest Qtr	0.99	4.81	0.53	-79.4%	86.8%

* Standalone data

Detailed Results

Jagsonpal Pharmaceuticals Ltd.

06 May 2025

220.72

1.76%

Board Meeting

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the following: 1. Audited (Standalone) Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2025. 2. The Board recommended a dividend of Rs. 2.5/- (125%) per equity share having face value of Rs. 2 for the financial year ended March 31, 2025. 3. Appointment of M/s. S S Kothari Mehta & Co., Chartered Accountants as Internal Auditor of the Company for FY 2025-26. The Board Meeting commenced at 5:10 p.m. and concluded at 5:46 p.m.

pdf

Jagsonpal Pharmaceuticals Ltd.

30 Apr 2025

220.72

1.76%

Company Update

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Analysts/Investors Conference call on Wednesday May 07, 2025, to discuss Q4 FY 25 financial results.

pdf

Jagsonpal Pharmaceuticals Ltd.

29 Apr 2025

220.72

1.76%

Board Meeting

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Consideration Of Financial Results For The …

BSE India

Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve Financial results for the quarter and year ended March 31, 2025 and recommendation of Dividend, if any, for the financial year ended March 31, 2025

pdf